Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1500 of 6351
-
Experimental cell therapy takes on tough blood disorder
Disease control Not yet recruitingThis is a Phase I, single-arm, open-label, dose-escalation and dose-expansion study. The primary objective is to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of YTS109 STAR-T cell therapy in patients with autoimmune hemolytic anemia who have…
Phase 1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for young cancer patients: drug may fix Chemo-Related low platelets
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of romiplostim N01 in treating chemotherapy-induced thrombocytopenia (CIT) in children and adolescents/young adults (CAYA; aged 6-24 years) with hematologic malignancies or solid tumors. The main questions it …
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Video game therapy could replace eye patches for lazy eye
Disease control Recruiting nowThis is a prospective, single-arm, non-inferiority clinical trial designed to evaluate the efficacy, safety, and adherence of AmblyoFix binocular digital therapy for the treatment of unilateral amblyopia in children aged 7 to 12 years. Outcomes will be compared against a retrospe…
Sponsor: Eyesight Electronics • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Gene editing for hepatitis b: researchers track Long-Term safety
Disease control By invitation onlyParticipants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.
Sponsor: Precision BioSciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New scan could spot hidden myeloma lesions
Diagnosis Recruiting nowThis is a prospective, multicenter diagnostic imaging study designed to evaluate the diagnostic accuracy and clinical utility of BCMA-targeted positron emission tomography/computed tomography (PET/CT) in patients with multiple myeloma and related plasma cell disorders. The study …
Phase 2/3 • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
New asthma drug QL2302 goes Head-to-Head with tezspire in major trial
Disease control Not yet recruitingThe goal of this clinical trial is to compare the efficacy and safety of QL2302 and Tezspire® in patients with uncontrolled severe asthma. The main questions it aims to answer are: * if the efficacy of QL2302 and Tezspire® are similar * if the safety of QL2302 and Tezspire® are …
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New study tests if removing stents earlier prevents fluid return after pancreatic necrosis treatment
Disease control Recruiting nowIn adults with walled-off pancreatic necrosis (WON) undergoing endoscopic ultrasound (EUS)-guided transluminal necrosectomy, does early removal of the lumen-apposing metal stent (LAMS) (at 2 weeks or immediately after the last necrosectomy) with placement of a double-pigtail plas…
Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI reads scans and genes to predict lung cancer drug success
Knowledge-focused Not yet recruitingThe main purpose of this study is to explore the value of multimodal imaging information and models in predicting the prognosis of EGFR-positive non-small cell lung cancer patients undergoing targeted therapy, providing a basis for selecting suitable populations for precise tumor…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Can cutting certain carbs or gluten calm irritable bowel syndrome?
Disease control CompletedIrritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder characterized by recurrent abdominal pain and irregular bowel habits. Dietary interventions, particularly low-FODMAP and gluten-free diets, have gained increasing interest in IBS management. However, …
Sponsor: Ertuğrul Çoruh • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a Two-Drug punch knock out CMV faster in lung transplants?
Disease control Recruiting nowThe primary objective of the CLEAR-CMV trial is to evaluate the efficacy of letermovir therapy plus standard of care (SOC) antiviral compared to SOC plus placebo in achieving clearance of CMV viremia by week 3 in lung transplant recipients with active CMV infection.
Phase 4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New device aims to break vaping addiction without drugs
Disease control Recruiting nowThis clinical trial evaluates the VapeAway system, a novel, multi-modal intervention designed to address the multifaceted nature of vaping addiction. VapeAway combines progressive nicotine tapering via proprietary filters, behavioral substitution with a sensory device (Fix Bar), …
Phase 2 • Sponsor: VapeAway • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New app aims to stop Kids' eyes from getting worse during screen time
Disease control Recruiting nowThe DYMOND study evaluates the safety and effectiveness of TrackSight™, a digital medical application designed to slow myopia (nearsightedness) progression in children during everyday screen use. TrackSight uses eye-tracking technology to keep central vision clear while subtly ad…
Phase 2 • Sponsor: NovaSight • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Blood test may help personalize breast cancer therapy
Disease control Recruiting nowThis is an exploratory, ctDNA-guided, multi-stage clinical study designed to evaluate the clinical value of treatment decision-making based on circulating tumor DNA (ctDNA) variant allele frequency (VAF) dynamics in patients with HER2-negative metastatic breast cancer. All enrol…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New iron supplement could help celiac kids recover faster
Disease control Recruiting nowCeliac disease in children is frequently associated with iron deficiency and/or iron deficiency anemia due to intestinal malabsorption and chronic inflammation. Although a gluten-free diet is the standard treatment and can restore iron balance over time, there is currently no cle…
Sponsor: Istituto Giannina Gaslini • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can an antiviral drug stop RSV in vulnerable patients?
Disease control Recruiting nowThis phase II trial tests how well remdesivir works for treatment of respiratory syncytial virus (RSV) infection of the upper respiratory tract in patients receiving cellular or bispecific antibody therapy. Cellular or bispecific antibody therapies cause suppression of the immune…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a common ALS drug prevent chemotherapy brain fog?
Prevention Recruiting nowThis is a phase II single-arm, Phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining efficacy of riluzole in preventing cognitive dysfunction in subjects with cancer, who are receiving chemotherapy.
Phase 2 • Sponsor: University of California, Irvine • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Can a targeted nerve block replace opioids for chemoport surgery?
Symptom relief CompletedChemoport implantation is frequently performed in patients with cancer requiring long-term intravenous chemotherapy. Local infiltration anesthesia (LIA) remains the conventional anesthetic technique for this procedure. However, it often provides incomplete analgesia because senso…
Sponsor: Indonesia University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
New drug cocktail aims to tackle Hard-to-Treat cancers
Disease control Recruiting nowThis study aims to evaluate the safety, tolerability and efficacy of SHR-7787 in combination with other anti-tumor drugs in patients with malignant solid tumors.
Phase 2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New scalp implant may unlock better epilepsy care for hard-to-diagnose patients
Knowledge-focused Recruiting nowThe purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring tech…
Sponsor: Epiminder America, Inc. • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Magic mushroom compound probed as brain tool against opioid addiction
Knowledge-focused Recruiting nowThe goal of this study is to test addiction-related brain circuitry (motivation/reward and inhibition) as well as neurocognitive circuitry prior to and following low or high dose psilocybin (PEX010 from Filament). Using fMRI, brain circuits will be examined that are relevant to d…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC